Julia Kenny

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

F. Fitzgerald, A. Sarah Walker, V. Mulenga, 2018, The Journal of infectious diseases.

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

C. Giaquinto, N. Klein, T. Bunupuradah, 2016, The lancet. HIV.

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial

A. Walker, N. Klein, V. Mulenga, 2016, The Lancet. Infectious diseases.